News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

STAT3 as a Target in H3K27M-mutant DMGs

News

October 9, 2023
PRESS RELEASE: On October 4, 2023, a new editorial perspective was published in Oncotarget, entitled, “STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma.” continue reading »

Lurbinectedin for Neuroendocrine Tumors (NETs)

News

October 6, 2023
PRESS RELEASE: On June 14, 2023, a new editorial was published in Oncoscience, entitled, “Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.” continue reading »

AI Model for Age-Related Disease Target Discovery

Aging

October 4, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 18, entitled, “Biomedical generative pre-trained based transformer language model for age-related disease target discovery.” continue reading »

UGDH in Clinical Oncology and Cancer Biology

News

October 4, 2023
PRESS RELEASE: On September 28, 2023, a new review was published in Oncotarget, entitled, “UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology.” continue reading »

An Ancient Anti-cancer Mechanism: DISE

News

October 3, 2023
PRESS RELEASE: On September 25, 2023, a new editorial was published in Oncotarget, entitled, “DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells?” continue reading »